Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort

Raymond H Chan1, Laurine van der Wal2, Gabriela Liberato3

  • 1Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

JAMA Cardiology
|September 25, 2024
PubMed

Insights

Late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) imaging predicts sudden cardiac death (SCD) in children and adolescents with hypertrophic cardiomyopathy (HCM). This finding improves risk stratification for these young patients.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Pediatrics

Background:

  • Predicting sudden cardiac death (SCD) in pediatric hypertrophic cardiomyopathy (HCM) remains challenging.
  • Late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) imaging is linked to SCD in adult HCM patients.

Purpose of the Study:

  • To assess the prognostic value of LGE in predicting SCD in patients under 21 years with HCM.
  • To determine if LGE improves existing risk stratification models for pediatric HCM.

Main Methods:

  • A multicenter, retrospective cohort study involving 700 patients (<21 years) with HCM who underwent CMR.
  • Follow-up for SCD and surrogate events, with LGE presence and burden quantified.
  • Kaplan-Meier and Cox proportional hazards models were used for analysis.

Main Results:

  • LGE was present in 32.9% of patients and associated with a higher risk of SCD.
  • A higher LGE burden (≥10%) significantly increased SCD risk (HR, 2.19).
  • Incorporating LGE burden improved the predictive performance of established risk scores like HCM Risk-Kids and Precision Medicine in Cardiomyopathy.

Conclusions:

  • Quantitative LGE is a significant risk factor for SCD in pediatric HCM patients.
  • LGE assessment enhances the accuracy of risk stratification for young individuals with HCM.
  • This highlights the importance of LGE in managing pediatric HCM and preventing SCD.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
2
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2